Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway in BRAF-mutated melanoma cells, as A375 cells, can promote hypoxia inducible factor-1 alpha (HIF1α) expression, hence leading to a high glycolytic rate [48]. This evidence concerns the gene MAPK1 and melanoma.